Long-term mortality after DOAC-associated intracranial haemorrhage

Thromb Res. 2019 Apr:176:30-32. doi: 10.1016/j.thromres.2019.02.007. Epub 2019 Feb 11.

Authors

Christopher Beynon¹, Oliver W Sakowitz², Andreas W Unterberg³

Affiliations

¹ Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: christopher.beynon@med.uni-heidelberg.de.
² Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany; Department of Neurosurgery, Ludwigsburg Hospital, Ludwigsburg, Germany.
³ Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.

PMID: 30771644
DOI: 10.1016/j.thromres.2019.02.007

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Aged
Aged, 80 and over
Factor Xa Inhibitors / adverse effects*
Factor Xa Inhibitors / therapeutic use
Female
Humans
Intracranial Hemorrhages / chemically induced*
Intracranial Hemorrhages / mortality
Male
Mortality
Thromboembolism / drug therapy*

Substances

Factor Xa Inhibitors